title: [CREST syndrome and pulmonary hypertension: a dark prognosis].
abstract: The CREST syndrome initially described as a limited, more indolent form of diffuse scleroderma, is characterized by calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasias. Subsequent studies showed that visceral abnormalities were not uncommon. Pulmonary abnormalities are frequent especially pulmonary hypertension, this one being a major cause of this syndrome's mortality. The authors present the case of white woman, 61 years old , with dyspnoea, cyanosis and peripheral edema with 12 months of evolution. She was admitted for pulmonary thromboembolism suspicion. After investigation the diagnosis of CREST syndrome was made, associated with severe pulmonary hypertension. The patient was treated with varfarina, nicorandil, nifedipine, furosemide and home oxygen. She died 3 months after. The authors discuss the diagnosis, treatment and follow-up.
authors.affiliation: Serviço de Medicina A, Hospital de S. João, Porto.
authors.forename: Ana C
authors.initials: AC
authors.lastname: Carneiro
authors.forename: Isabel P
authors.initials: IP
authors.lastname: Barbosa
authors.forename: F Carneiro
authors.initials: FC
authors.lastname: Chaves
mesh_terms: D017675:CREST Syndrome / Q000150:complications*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications*; D008875:Middle Aged; D011379:Prognosis